XML 10 R4.htm IDEA: XBRL DOCUMENT v3.24.3
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
 3 Months Ended 9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Sep. 30, 2024
Sep. 30, 2023
Expenses        
Research and development $ 1,887,913 $ 3,443,537 $ 9,915,699 $ 7,984,566
General and administrative 2,478,787 2,635,583 7,410,532 7,963,067
Total expenses 4,366,700 6,079,120 17,326,231 15,947,633
Loss from operations (4,366,700) (6,079,120) (17,326,231) (15,947,633)
Foreign exchange losses (13,108) (5,096) (12,309) (20,988)
Investment income 313,967 348,681 1,032,630 1,078,522
Non-cash interest expense for the sale of future royalties 0 (2,084,911) (4,562,223) (6,092,795)
Other income 26,579,046   26,579,046  
Net income (loss) $ 22,513,205 $ (7,820,446) $ 5,710,913 $ (20,982,894)
Net income (loss) per share, basic $ 2.97 $ (1.03) $ 0.75 $ (3.41)
Net income (loss) per share, diluted $ 2.97 $ (1.03) $ 0.75 $ (3.41)
Weighted average shares outstanding, basic 7,568,981 7,568,981 7,568,981 6,148,276
Weighted average shares outstanding, diluted 7,568,981 7,568,981 7,578,267 6,148,276